| 000 | 02407 a2200685 4500 | ||
|---|---|---|---|
| 005 | 20250517053546.0 | ||
| 264 | 0 | _c20151224 | |
| 008 | 201512s 0 0 eng d | ||
| 022 | _a0946-1965 | ||
| 024 | 7 |
_a10.5414/CP202391 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aZhou, Xinna | |
| 245 | 0 | 0 |
_aTransformation of alkylating regimen of thiotepa into tepa determines the disease progression through GSTP1 gene polymorphism for metastatic breast cancer patients receiving thiotepa containing salvage chemotherapy. _h[electronic resource] |
| 260 |
_bInternational journal of clinical pharmacology and therapeutics _cNov 2015 |
||
| 300 |
_a914-22 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Agents, Alkylating _xadverse effects |
| 650 | 0 | 4 | _aBiotransformation |
| 650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aChina |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP2B6 _xgenetics |
| 650 | 0 | 4 |
_aCytochrome P-450 CYP3A _xgenetics |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDisease-Free Survival |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aGlutathione S-Transferase pi _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLogistic Models |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPatient Selection |
| 650 | 0 | 4 | _aPharmacogenetics |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aRetrospective Studies |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSalvage Therapy |
| 650 | 0 | 4 | _aSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
| 650 | 0 | 4 |
_aThiotepa _xadverse effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTriethylenephosphoramide _xadverse effects |
| 700 | 1 | _aWang, Xiaoli | |
| 700 | 1 | _aSong, Qingkun | |
| 700 | 1 | _aYang, Huabing | |
| 700 | 1 | _aZhu, Xishan | |
| 700 | 1 | _aYu, Jing | |
| 700 | 1 | _aSong, Guohong | |
| 700 | 1 | _aDi, Lijun | |
| 700 | 1 | _aRen, Jun | |
| 700 | 1 | _aShao, Hong | |
| 700 | 1 | _aLyerly, Herbert Kim | |
| 773 | 0 |
_tInternational journal of clinical pharmacology and therapeutics _gvol. 53 _gno. 11 _gp. 914-22 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5414/CP202391 _zAvailable from publisher's website |
| 999 |
_c25285933 _d25285933 |
||